Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PROKETAZINE

CARPHENAZINE MALEATE

Standard Dose
50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PROKETAZINE is listed in Drugs@FDA under application 014173 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CARPHENAZINE MALEATE Form and strength CONCENTRATE;ORAL - 50MG/ML Sponsor WYETH AYERST Submission history Latest submission status date: 1963-03-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROKETAZINE is listed in Drugs@FDA under application 014173 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CARPHENAZINE MALEATE Form and strength CONCENTRATE;ORAL - 50MG/ML Sponsor WYETH AYERST Submission history Latest submission status date: 1963-03-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.